INTERNATIONAL PATENT: SR-BIOPHARMA GROUP CO., LTD., SR BIOPHARMA PTE. LTD FILES APPLICATION FOR "THE USE OF POKEWEED ANTIVIRAL PROTEIN ISOFORM ONE (PAP-I) FOR THE TREATMENT OF HUMAN PAPILLOMA VIRUS (HPV) INFECTION AND HPV-ASSOCIATED DISEASES"

GENEVA, March 24 -- SR-BIOPHARMA GROUP CO., LTD. (No.5 Medicine valley 1st Road,Haikou National Hi-Tech Industrial Development Zone,Haikou, Hainan), SR BIOPHARMA PTE. LTD (61 Biopolis Drive, #02-08 Proteos,Singapore 138673) filed a patent application (PCT/SG2025/050291) for "THE USE OF POKEWEED ANTIVIRAL PROTEIN ISOFORM ONE (PAP-I) FOR THE TREATMENT OF HUMAN PAPILLOMA VIRUS (HPV) INFECTION AND HPV-ASSOCIATED DISEASES" on Apr 30, 2025. With publication no. WO/2026/059487, the details related to the patent application was published on Mar 19, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ZHA...